BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32883299)

  • 1. Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML.
    Smith JS; Lappin KM; Craig SG; Liberante FG; Crean CM; McDade SS; Thompson A; Mills KI; Savage KI
    J Transl Med; 2020 Sep; 18(1):339. PubMed ID: 32883299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML.
    Tothova Z; Valton AL; Gorelov RA; Vallurupalli M; Krill-Burger JM; Holmes A; Landers CC; Haydu JE; Malolepsza E; Hartigan C; Donahue M; Popova KD; Koochaki S; Venev SV; Rivera J; Chen E; Lage K; Schenone M; D'Andrea AD; Carr SA; Morgan EA; Dekker J; Ebert BL
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular pathogenesis of myelodysplastic syndromes with concurrent mutations in cohesin STAG2 and transcription factor RUNX1].
    Ochi Y
    Rinsho Ketsueki; 2021; 62(5):352-359. PubMed ID: 34108313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.
    Viny AD; Bowman RL; Liu Y; Lavallée VP; Eisman SE; Xiao W; Durham BH; Navitski A; Park J; Braunstein S; Alija B; Karzai A; Csete IS; Witkin M; Azizi E; Baslan T; Ott CJ; Pe'er D; Dekker J; Koche R; Levine RL
    Cell Stem Cell; 2019 Nov; 25(5):682-696.e8. PubMed ID: 31495782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes.
    Ochi Y; Kon A; Sakata T; Nakagawa MM; Nakazawa N; Kakuta M; Kataoka K; Koseki H; Nakayama M; Morishita D; Tsuruyama T; Saiki R; Yoda A; Okuda R; Yoshizato T; Yoshida K; Shiozawa Y; Nannya Y; Kotani S; Kogure Y; Kakiuchi N; Nishimura T; Makishima H; Malcovati L; Yokoyama A; Takeuchi K; Sugihara E; Sato TA; Sanada M; Takaori-Kondo A; Cazzola M; Kengaku M; Miyano S; Shirahige K; Suzuki HI; Ogawa S
    Cancer Discov; 2020 Jun; 10(6):836-853. PubMed ID: 32249213
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromatin organization in myelodysplastic syndrome.
    Xu JJ; Viny AD
    Exp Hematol; 2024 Jun; 134():104216. PubMed ID: 38582293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohesin mutations in myeloid malignancies made simple.
    Viny AD; Levine RL
    Curr Opin Hematol; 2018 Mar; 25(2):61-66. PubMed ID: 29278534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming.
    Chu Z; Gu L; Hu Y; Zhang X; Li M; Chen J; Teng D; Huang M; Shen CH; Cai L; Yoshida T; Qi Y; Niu Z; Feng A; Geng S; Frederick DT; Specht E; Piris A; Sullivan RJ; Flaherty KT; Boland GM; Georgopoulos K; Liu D; Shi Y; Zheng B
    Nat Commun; 2022 Apr; 13(1):1859. PubMed ID: 35388001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
    Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
    Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells.
    Richart L; Lapi E; Pancaldi V; Cuenca-Ardura M; Pau EC; Madrid-Mencía M; Neyret-Kahn H; Radvanyi F; Rodríguez JA; Cuartero Y; Serra F; Le Dily F; Valencia A; Marti-Renom MA; Real FX
    Nucleic Acids Res; 2021 Nov; 49(19):11005-11021. PubMed ID: 34648034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consequences of cohesin mutations in myeloid malignancies.
    Bhattacharya SA; Dias E; Nieto-Aliseda A; Buschbeck M
    Front Mol Biosci; 2023; 10():1319804. PubMed ID: 38033389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control.
    Casa V; Moronta Gines M; Gade Gusmao E; Slotman JA; Zirkel A; Josipovic N; Oole E; van IJcken WFJ; Houtsmuller AB; Papantonis A; Wendt KS
    Genome Res; 2020 Apr; 30(4):515-527. PubMed ID: 32253279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiforme.
    Xu W; Kim JS; Yang T; Ya A; Sadzewicz L; Tallon L; Harris BT; Sarkaria J; Jin F; Waldman T
    J Biol Chem; 2024 May; 300(6):107341. PubMed ID: 38705393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of the cohesin complex genes in myeloid malignancies.
    Thota S; Viny AD; Makishima H; Spitzer B; Radivoyevitch T; Przychodzen B; Sekeres MA; Levine RL; Maciejewski JP
    Blood; 2014 Sep; 124(11):1790-8. PubMed ID: 25006131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
    Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
    Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
    Thol F; Bollin R; Gehlhaar M; Walter C; Dugas M; Suchanek KJ; Kirchner A; Huang L; Chaturvedi A; Wichmann M; Wiehlmann L; Shahswar R; Damm F; Göhring G; Schlegelberger B; Schlenk R; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
    Blood; 2014 Feb; 123(6):914-20. PubMed ID: 24335498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
    Surdez D; Zaidi S; Grossetête S; Laud-Duval K; Ferre AS; Mous L; Vourc'h T; Tirode F; Pierron G; Raynal V; Baulande S; Brunet E; Hill V; Delattre O
    Cancer Cell; 2021 Jun; 39(6):810-826.e9. PubMed ID: 33930311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
    Martín-Izquierdo M; Abáigar M; Hernández-Sánchez JM; Tamborero D; López-Cadenas F; Ramos F; Lumbreras E; Madinaveitia-Ochoa A; Megido M; Labrador J; Sánchez-Real J; Olivier C; Dávila J; Aguilar C; Rodríguez JN; Martín-Nuñez G; Santos-Mínguez S; Miguel-García C; Benito R; Díez-Campelo M; Hernández-Rivas JM
    Haematologica; 2021 Aug; 106(8):2215-2223. PubMed ID: 32675227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAG2 promotes the myelination transcriptional program in oligodendrocytes.
    Cheng N; Li G; Kanchwala M; Evers BM; Xing C; Yu H
    Elife; 2022 Aug; 11():. PubMed ID: 35959892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.